Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 72, Issue 7
Volume 72, Issue 7
1 April 2021
ISSN 1058-4838
EISSN 1537-6591

Volume 72, Issue 7, 1 April 2021

IN THE LITERATURE

Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages i–ii, https://doi.org/10.1093/cid/ciab173

IDSA FEATURES

Pranita D Tamma and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1109–1116, https://doi.org/10.1093/cid/ciab295

MAJOR ARTICLES AND COMMENTARIES

Louis B Polish and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1117–1123, https://doi.org/10.1093/cid/ciaa245

We have identified the first case of a European haplotype Echinococcus multilocularis in the United States. Given the recent identification of this haplotype in Canada, this may be an emerging infectious disease in North America.

Peter Kern
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1124–1126, https://doi.org/10.1093/cid/ciaa257
Getahun Abate and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1127–1137, https://doi.org/10.1093/cid/ciaa252

Mycobacterium avium-intracellulare complex, M. kansasii, and M. abscessus were the most common cause of pulmonary Nontuberculous Mycobacterial Disease (NTM). Mangement of pulmonary NTM was heterogenous and cure rate was low. Adherence to ATS/IDSA guidelines and follow-up of selected patients without treatment are important.

Max Salfinger and Akos Somoskovi
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1138–1140, https://doi.org/10.1093/cid/ciaa250
Daniel D Murray and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1141–1146, https://doi.org/10.1093/cid/ciaa748

We describe T-cell reconstitution postallogeneic stem cell transplantation in 6 people with human immunodeficiency virus (HIV) compared to 21 controls without HIV. We observed a significantly elevated CD8+ T-cell expansion post-Allogeneic Stem Cell Transplant in recipients with HIV. The nature and specificity of the CD8+ T-cell population differed among individuals.

Manjusha Gaglani and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1147–1157, https://doi.org/10.1093/cid/ciaa102

During the 4 influenza seasons beginning in 2013–2014, trivalent and quadrivalent inactivated influenza vaccines provided equivalent protection against any influenza B illness in the United States, while quadrivalent vaccines provided better protection against the added B virus lineage.

Marian Loveday and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1158–1168, https://doi.org/10.1093/cid/ciaa189

Pregnant women with Multidrug/Rifampicin-resistant-tuberculosis can be effectively and safely treated. We observed a relationship between the use of bedaquiline and low birth weight, but the clinical importance of this finding is unclear.

Ben J Marais
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1169–1170, https://doi.org/10.1093/cid/ciaa174
Sophia G de Vries and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1171–1178, https://doi.org/10.1093/cid/ciaa091

Rickettsial disease is an important and poorly recognized cause of illness in travelers, specifically when an inoculation eschar is absent. A lower threshold to test and treat is warranted in returning travelers with febrile illness, regardless of eschar presence.

Didier Raoult
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1179–1180, https://doi.org/10.1093/cid/ciaa096
Harold C Wiesenfeld and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1181–1189, https://doi.org/10.1093/cid/ciaa101

Treatment of acute pelvic inflammatory disease with ceftriaxone, doxycycline, and metronidazole is associated with significantly less frequent recovery of anaerobic organisms from the upper genital tract, decreased Mycoplasma genitalium, and improved clinical response compared to ceftriaxone and doxycycline.

Caroline Mitchell
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1190–1191, https://doi.org/10.1093/cid/ciaa103
Laura Krogh Herlin and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1192–1199, https://doi.org/10.1093/cid/ciaa185

We identified 92 adults with Varicella Zoster Virus encephalitis primarily affecting elderly or immunocompromised patients. Diagnosis and treatment are often delayed; cerebral vasculitis is not uncommon (16%). Risk factors for unfavorable outcome are age, cerebral vasculitis, and Glasgow Coma Scale score <15.

Ron Dagan and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1200–1207, https://doi.org/10.1093/cid/ciaa197

Thirteen-valent pneumococcal conjugate vaccine led to a decline in pneumococcal and all-cause bacterial conjunctivitis. As with observations in otitis media, reduction occurred also in diseases caused by nontypeable Haemophilus influenzae, suggesting its interaction with pneumococcus in conjunctivitis pathogenesis.

Leigh M Howard and Annabelle de St. Maurice
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1208–1210, https://doi.org/10.1093/cid/ciaa202
Marc Bonten and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1211–1219, https://doi.org/10.1093/cid/ciaa210

This systematic review regarding the epidemiology of Escherichia coli bacteremia in high-income countries shows that the disease burden is greatest in the elderly, and that most episodes have a community onset and result from urinary tract infection.

Margaret L Lind and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1220–1229, https://doi.org/10.1093/cid/ciaa214

Sepsis disproportionately affects hematopoietic cell transplant (HCT) recipients, but clinical criteria currently recommended in sepsis detection have not been validated in these patients. We demonstrate the limited predictive value of commonly used clinical criteria among HCT recipients with suspected infections.

Erica Stohs and Andre C Kalil
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1230–1231, https://doi.org/10.1093/cid/ciaa221
Arthur W Baker and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1232–1240, https://doi.org/10.1093/cid/ciaa215

Cardiac surgery patients with invasive Mycobacterium abscessus complex infection received aggressive and prolonged medical and surgical therapy. However, patients with these infections experienced substantial morbidity and mortality. Novel treatment strategies are needed, and close attention to infection prevention remains paramount.

BRIEF REPORTS

Arielle R Nagler and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1241–1243, https://doi.org/10.1093/cid/ciaa867
Russell R Kempker and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1244–1246, https://doi.org/10.1093/cid/ciaa877
Boghuma K Titanji and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1247–1250, https://doi.org/10.1093/cid/ciaa879
Heinz-Josef Lenz and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1251–1252, https://doi.org/10.1093/cid/ciaa940
Swetha Pinninti and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1253–1255, https://doi.org/10.1093/cid/ciaa882
Emiel Leegwater and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1256–1258, https://doi.org/10.1093/cid/ciaa883

VIEWPOINTS

Mical Paul and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1259–1264, https://doi.org/10.1093/cid/ciaa930

Costs of investigator-initiated trials are lower than those of industry-sponsored trials. We present our viewpoint on the sources of these costs and compare trials’ aims and methods. We propose a greater role for academic clinical trials networks, especially for antibiotic development.

Mark J Siedner and Rajesh T Gandhi
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1265–1267, https://doi.org/10.1093/cid/ciaa945

We propose a minimum set of trial characteristics and results to be released simultaneously with clinical trial announcements.

REVIEW ARTICLE

Elvis Temfack and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1268–1278, https://doi.org/10.1093/cid/ciaa1243

In patients with symptoms suspicious of cryptococcal meningitis (CM) associated with human immunodeficiency virus, a positive serum cryptococcal antigen (CrAg) is highly presumptive of culture-confirmed CM and a positive cerebrospinal fluid CrAg is diagnostic of a first episode of CM.

INVITED ARTICLE

CLINICAL PRACTICE

William F Wright and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1279–1286, https://doi.org/10.1093/cid/ciaa1220

Data suggests 2-deoxy-2-[18F]fluoro-D-glucose–positron emission tomography/computed tomography is a useful imaging technique for the evaluation of fever of unknown origin as it improves diagnostic efficiency and reduces costs. Clinicians should consider this useful tool when preliminary studies are unrevealing.

PHOTO QUIZ

Ugo Françoise and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1287–1289, https://doi.org/10.1093/cid/ciaa1651

CORRESPONDENCE

Bing Qu and Jing Yang
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1290–1291, https://doi.org/10.1093/cid/ciaa551
Yutaro Yamaoka and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1291–1292, https://doi.org/10.1093/cid/ciaa637
Li Guo and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Page 1293, https://doi.org/10.1093/cid/ciaa687
Ashish Kumar Kakkar and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1293–1295, https://doi.org/10.1093/cid/ciaa847
Hitoshi Honda and Shutaro Murakami
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1295–1296, https://doi.org/10.1093/cid/ciaa842
Davide Mangioni and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1296–1297, https://doi.org/10.1093/cid/ciaa846
Sijia Li and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1297–1298, https://doi.org/10.1093/cid/ciaa829
Yanfei Chen and Lanjuan Li
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages 1298–1300, https://doi.org/10.1093/cid/ciaa832

ONLINE ONLY ARTICLES

Pranita D Tamma and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages e169–e183, https://doi.org/10.1093/cid/ciaa1478
Kyungmin Huh and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages e184–e191, https://doi.org/10.1093/cid/ciaa1682

In this ecological study using a nationwide notifiable diseases database and a sample surveillance, implementation of nonpharmaceutical interventions was associated with significantly lower incidences of chickenpox, mumps, and respiratory virus infections compared with the prediction model or the preintervention period.

Klara M Posfay-Barbe and others
Clinical Infectious Diseases, Volume 72, Issue 7, 1 April 2021, Pages e192–e195, https://doi.org/10.1093/cid/ciaa1702
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close